financetom
Business
financetom
/
Business
/
Southern Silver Exploration to Raise $4.0 Million Via Non-Brokered LIFE Private Placement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Southern Silver Exploration to Raise $4.0 Million Via Non-Brokered LIFE Private Placement
May 14, 2026 12:31 PM

03:04 PM EDT, 05/14/2026 (MT Newswires) -- Southern Silver Exploration ( SSVFF ) is proposing to undertake a non-brokered private placement consisting of up to near 6.7-million common shares at $0.60 for gross proceeds of up to $4.0 million, the company said Thursday.

Closing of the offering is scheduled on or about June 5, 2026, or such other date as the company determines. Proceeds will be used for the advancement of the Cerro Las Minitas project as well as for working capital and general corporate needs, it added.

Shares were last seen down 4.6% at $0.62 on the TSX Venture Exchange.

Price: 0.62, Change: -0.03, Percent Change: -4.62

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3
Form 8.3
Jun 24, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Antares Therapeutics signs potential $1.9 billion cancer drug deal with Novartis
Antares Therapeutics signs potential $1.9 billion cancer drug deal with Novartis
Jun 24, 2026
June 24 (Reuters) - Antares Therapeutics said on Wednesday it entered a collaboration with Novartis that could be worth up to about $1.9 billion, aiming to develop therapies for historically hard-to-drug cancer targets. Here are some details of the deal: * Antares Therapeutics said it will receive $105 million upfront under the agreement with Novartis. * The biotech is also...
Form 8.3
Form 8.3
Jun 24, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Gaxos.ai Inc. Sells Gaming Assets to Game Foundry AI
Gaxos.ai Inc. Sells Gaming Assets to Game Foundry AI
Jun 24, 2026
Transaction streamlines operations and positions Gaxos to focus on revenue-generating, higher-margin opportunities Roseland, NJ, June 24, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ( GXAI ) (Gaxos or the Company), a company developing artificial intelligence applications across various high-growth sectors, today announced that it had completed the sale of its gaming assets, including its portfolio of mobile games and Gaxos Gaming...
Copyright 2023-2026 - www.financetom.com All Rights Reserved